1. Home
  2. GOGO vs ADPT Comparison

GOGO vs ADPT Comparison

Compare GOGO & ADPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GOGO
  • ADPT
  • Stock Information
  • Founded
  • GOGO 1991
  • ADPT 2009
  • Country
  • GOGO United States
  • ADPT United States
  • Employees
  • GOGO N/A
  • ADPT N/A
  • Industry
  • GOGO Telecommunications Equipment
  • ADPT Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • GOGO Consumer Discretionary
  • ADPT Health Care
  • Exchange
  • GOGO Nasdaq
  • ADPT Nasdaq
  • Market Cap
  • GOGO 1.0B
  • ADPT 1.2B
  • IPO Year
  • GOGO 2013
  • ADPT 2019
  • Fundamental
  • Price
  • GOGO $7.96
  • ADPT $8.27
  • Analyst Decision
  • GOGO Buy
  • ADPT Buy
  • Analyst Count
  • GOGO 3
  • ADPT 5
  • Target Price
  • GOGO $12.17
  • ADPT $9.10
  • AVG Volume (30 Days)
  • GOGO 998.1K
  • ADPT 1.4M
  • Earning Date
  • GOGO 03-03-2025
  • ADPT 02-11-2025
  • Dividend Yield
  • GOGO N/A
  • ADPT N/A
  • EPS Growth
  • GOGO N/A
  • ADPT N/A
  • EPS
  • GOGO 0.43
  • ADPT N/A
  • Revenue
  • GOGO $404,720,000.00
  • ADPT $178,957,000.00
  • Revenue This Year
  • GOGO $3.79
  • ADPT $20.07
  • Revenue Next Year
  • GOGO $10.69
  • ADPT $25.27
  • P/E Ratio
  • GOGO $18.33
  • ADPT N/A
  • Revenue Growth
  • GOGO N/A
  • ADPT 5.10
  • 52 Week Low
  • GOGO $6.17
  • ADPT $2.28
  • 52 Week High
  • GOGO $11.00
  • ADPT $8.95
  • Technical
  • Relative Strength Index (RSI)
  • GOGO 47.66
  • ADPT 58.94
  • Support Level
  • GOGO $7.56
  • ADPT $8.09
  • Resistance Level
  • GOGO $8.71
  • ADPT $8.69
  • Average True Range (ATR)
  • GOGO 0.40
  • ADPT 0.64
  • MACD
  • GOGO -0.04
  • ADPT -0.00
  • Stochastic Oscillator
  • GOGO 41.86
  • ADPT 65.66

About GOGO Gogo Inc.

Gogo Inc is a broadband connectivity service for the business aviation market. It provides a customizable suite of smart cabin systems for integrated connectivity, inflight entertainment, and voice solutions. Its business segment includes Business Aviation. It generates two types of revenue: service revenue consists of monthly subscription and usage fees paid by aircraft owners and operators for telecommunication, data, and in-flight entertainment services. and equipment revenue consists of proceeds from the sale of ATG and narrowband satellite connectivity equipment and is recognized when control of the equipment is transferred to OEMs and dealers, which generally occurs when the equipment is shipped.

About ADPT Adaptive Biotechnologies Corporation

Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease (MRD) in patients with multiple myeloma (MM), B cell acute lymphoblastic leukemia (ALL) and chronic lymphocytic leukemia (CLL) and is also available as a CLIA-validated laboratory developed test (LDT) for patients with other lymphoid cancers, including diffuse large B-cell lymphoma (DLBCL).

Share on Social Networks: